maandag 5 juli 2010
Studiecommissie voor de vergrijzing: jaarlijks verslag 2010
Lees één van de belangrijkste overheidsrapporten van het jaar hier.
Leaving Germany for Turkey
High-quality immigrants are leaving
Déficit : “une dépense publique raisonnable, des impôts pour la financer”
Lisez la très intéressante analyse du Monde ici.
US claims of higher drug costs under fire
Claims by the US drugs industry that the US disproportionately funds research and development of new drugs by paying higher prices than Europe for its medicines have been undermined by a new study to be published soon. Panos Kanavos and Sotiri Vandoros at the London School of Economics argue in their report that a rigorous like-for-like comparison shows that transatlantic differences in patented medicine prices are modest and declining over time. Read the complete article in the Financial Times here.
A New Problem for Insurance Markets
The Feasibility to Regionalise Corporate Income Taxation
Read Professor Haelterman's Vives (KULeuven) discussion paper here.
Abonneren op:
Posts (Atom)